IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 203 filers reported holding IMMUNOGEN INC in Q4 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,630,296 | -15.1% | 480,800 | +1.0% | 0.01% | 0.0% |
| Q2 2023 | $8,984,007 | +445.6% | 476,100 | +11.0% | 0.01% | +500.0% |
| Q1 2023 | $1,646,592 | -30.8% | 428,800 | -10.6% | 0.00% | -50.0% |
| Q4 2022 | $2,378,816 | +5.7% | 479,600 | +1.9% | 0.00% | 0.0% |
| Q3 2022 | $2,250,000 | +6.9% | 470,700 | +0.7% | 0.00% | +100.0% |
| Q2 2022 | $2,104,000 | -7.8% | 467,500 | -2.4% | 0.00% | 0.0% |
| Q1 2022 | $2,281,000 | -31.0% | 479,100 | +7.6% | 0.00% | -50.0% |
| Q4 2021 | $3,304,000 | +31.9% | 445,300 | +0.8% | 0.00% | 0.0% |
| Q3 2021 | $2,505,000 | -11.3% | 441,800 | +3.1% | 0.00% | 0.0% |
| Q2 2021 | $2,823,000 | -18.6% | 428,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $3,470,000 | +36.1% | 428,400 | +8.4% | 0.00% | 0.0% |
| Q4 2020 | $2,550,000 | +79.2% | 395,300 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $1,423,000 | -20.0% | 395,300 | +2.3% | 0.00% | -50.0% |
| Q2 2020 | $1,778,000 | +57.2% | 386,600 | +16.6% | 0.00% | +100.0% |
| Q1 2020 | $1,131,000 | -22.8% | 331,700 | +15.6% | 0.00% | -50.0% |
| Q4 2019 | $1,465,000 | +115.8% | 286,900 | +2.2% | 0.00% | +100.0% |
| Q3 2019 | $679,000 | +15.1% | 280,600 | +3.3% | 0.00% | 0.0% |
| Q2 2019 | $590,000 | -19.8% | 271,700 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $736,000 | -41.8% | 271,700 | +3.1% | 0.00% | -50.0% |
| Q4 2018 | $1,265,000 | -47.4% | 263,500 | +3.7% | 0.00% | -33.3% |
| Q3 2018 | $2,405,000 | -2.7% | 254,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,471,000 | +7.4% | 254,000 | +16.2% | 0.00% | 0.0% |
| Q1 2018 | $2,300,000 | +122.7% | 218,600 | +35.6% | 0.00% | +200.0% |
| Q4 2017 | $1,033,000 | -2.3% | 161,200 | +16.6% | 0.00% | 0.0% |
| Q3 2017 | $1,057,000 | +7.5% | 138,200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $983,000 | +59.3% | 138,200 | -13.3% | 0.00% | 0.0% |
| Q1 2017 | $617,000 | +89.8% | 159,400 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $325,000 | -23.9% | 159,400 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $427,000 | -13.0% | 159,400 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $491,000 | -61.9% | 159,400 | +2.1% | 0.00% | -50.0% |
| Q1 2016 | $1,289,000 | -26.8% | 156,100 | +20.4% | 0.00% | -50.0% |
| Q4 2015 | $1,760,000 | +41.4% | 129,700 | 0.0% | 0.00% | +33.3% |
| Q3 2015 | $1,245,000 | -24.9% | 129,700 | +12.6% | 0.00% | -25.0% |
| Q2 2015 | $1,657,000 | +51.5% | 115,200 | -5.7% | 0.00% | +33.3% |
| Q1 2015 | $1,094,000 | +86.4% | 122,200 | +27.0% | 0.00% | +50.0% |
| Q4 2014 | $587,000 | -41.2% | 96,200 | +2.1% | 0.00% | -50.0% |
| Q3 2014 | $998,000 | -12.1% | 94,200 | -1.7% | 0.00% | 0.0% |
| Q2 2014 | $1,135,000 | -20.6% | 95,800 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $1,430,000 | +32.3% | 95,800 | +30.0% | 0.01% | +50.0% |
| Q4 2013 | $1,081,000 | -13.8% | 73,700 | 0.0% | 0.00% | -20.0% |
| Q3 2013 | $1,254,000 | -2.5% | 73,700 | -4.9% | 0.01% | -16.7% |
| Q2 2013 | $1,286,000 | – | 77,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
| Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
| Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
| Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
| HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
| Grace Capital | 49,500 | $228,000 | 0.20% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
| Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
| PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |